BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 23580231)

  • 21. Proprotein convertase subtilisin/kexin type 9 deficiency reduces melanoma metastasis in liver.
    Sun X; Essalmani R; Day R; Khatib AM; Seidah NG; Prat A
    Neoplasia; 2012 Dec; 14(12):1122-31. PubMed ID: 23308045
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annexin A2 is a natural extrahepatic inhibitor of the PCSK9-induced LDL receptor degradation.
    Seidah NG; Poirier S; Denis M; Parker R; Miao B; Mapelli C; Prat A; Wassef H; Davignon J; Hajjar KA; Mayer G
    PLoS One; 2012; 7(7):e41865. PubMed ID: 22848640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.
    Maxwell KN; Fisher EA; Breslow JL
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2069-74. PubMed ID: 15677715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of Porphyromonas gingivalis infection on post-transcriptional regulation of the low-density lipoprotein receptor in mice.
    Miyazawa H; Tabeta K; Miyauchi S; Aoki-Nonaka Y; Domon H; Honda T; Nakajima T; Yamazaki K
    Lipids Health Dis; 2012 Sep; 11():121. PubMed ID: 22992388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COPII collar defines the boundary between ER and ER exit site and does not coat cargo containers.
    Shomron O; Nevo-Yassaf I; Aviad T; Yaffe Y; Zahavi EE; Dukhovny A; Perlson E; Brodsky I; Yeheskel A; Pasmanik-Chor M; Mironov A; Beznoussenko GV; Mironov AA; Sklan EH; Patterson GH; Yonemura Y; Sannai M; Kaether C; Hirschberg K
    J Cell Biol; 2021 Jun; 220(6):. PubMed ID: 33852719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.
    Duan Y; Chen Y; Hu W; Li X; Yang X; Zhou X; Yin Z; Kong D; Yao Z; Hajjar DP; Liu L; Liu Q; Han J
    J Biol Chem; 2012 Jul; 287(28):23667-77. PubMed ID: 22593575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the C-terminal domain of PCSK9 and SEC24 isoforms in PCSK9 secretion.
    Deng SJ; Shen Y; Gu HM; Guo S; Wu SR; Zhang DW
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Jun; 1865(6):158660. PubMed ID: 32058034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective export of human GPI-anchored proteins from the endoplasmic reticulum.
    Bonnon C; Wendeler MW; Paccaud JP; Hauri HP
    J Cell Sci; 2010 May; 123(Pt 10):1705-15. PubMed ID: 20427317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mammalian COPII coat component SEC24C is required for embryonic development in mice.
    Adams EJ; Chen XW; O'Shea KS; Ginsburg D
    J Biol Chem; 2014 Jul; 289(30):20858-70. PubMed ID: 24876386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of Adiponectin Receptor Regulates Proprotein Convertase Subtilisin/Kexin Type 9 Expression and Inhibits Lesions in ApoE-Deficient Mice.
    Sun L; Yang X; Li Q; Zeng P; Liu Y; Liu L; Chen Y; Yu M; Ma C; Li X; Li Y; Zhang R; Zhu Y; Miao QR; Han J; Duan Y
    Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1290-1300. PubMed ID: 28546220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor-independent pathways.
    Cameron J; Bogsrud MP; Tveten K; Strøm TB; Holven K; Berge KE; Leren TP
    Transl Res; 2012 Aug; 160(2):125-30. PubMed ID: 22683370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels.
    Ferri N; Tibolla G; Pirillo A; Cipollone F; Mezzetti A; Pacia S; Corsini A; Catapano AL
    Atherosclerosis; 2012 Feb; 220(2):381-6. PubMed ID: 22176652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice.
    Roubtsova A; Chamberland A; Marcinkiewicz J; Essalmani R; Fazel A; Bergeron JJ; Seidah NG; Prat A
    J Lipid Res; 2015 Nov; 56(11):2133-42. PubMed ID: 26323289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proprotein convertase subtilisin kexin type 9 promotes intestinal overproduction of triglyceride-rich apolipoprotein B lipoproteins through both low-density lipoprotein receptor-dependent and -independent mechanisms.
    Rashid S; Tavori H; Brown PE; Linton MF; He J; Giunzioni I; Fazio S
    Circulation; 2014 Jul; 130(5):431-41. PubMed ID: 25070550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype.
    Maxwell KN; Breslow JL
    Proc Natl Acad Sci U S A; 2004 May; 101(18):7100-5. PubMed ID: 15118091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proprotein convertase PCSK9 induces the degradation of low density lipoprotein receptor (LDLR) and its closest family members VLDLR and ApoER2.
    Poirier S; Mayer G; Benjannet S; Bergeron E; Marcinkiewicz J; Nassoury N; Mayer H; Nimpf J; Prat A; Seidah NG
    J Biol Chem; 2008 Jan; 283(4):2363-72. PubMed ID: 18039658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structural basis of cargo membrane protein discrimination by the human COPII coat machinery.
    Mancias JD; Goldberg J
    EMBO J; 2008 Nov; 27(21):2918-28. PubMed ID: 18843296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ULK1 phosphorylates Sec23A and mediates autophagy-induced inhibition of ER-to-Golgi traffic.
    Gan W; Zhang C; Siu KY; Satoh A; Tanner JA; Yu S
    BMC Cell Biol; 2017 May; 18(1):22. PubMed ID: 28486929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.
    Ding Q; Strong A; Patel KM; Ng SL; Gosis BS; Regan SN; Cowan CA; Rader DJ; Musunuru K
    Circ Res; 2014 Aug; 115(5):488-92. PubMed ID: 24916110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transintestinal cholesterol excretion is an active metabolic process modulated by PCSK9 and statin involving ABCB1.
    Le May C; Berger JM; Lespine A; Pillot B; Prieur X; Letessier E; Hussain MM; Collet X; Cariou B; Costet P
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1484-93. PubMed ID: 23559630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.